Fifty1 Labs Partners with Stanford to Accelerate Antiviral Therapies Using AI
August 22, 2025 — Fifty1 Labs partners with ViRx@Stanford to use AI for rapid antiviral drug repurposing, accelerating pandemic response and strengthening global biosecurity against emerging viral threats.